Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Cell Immunol. 2017 Aug 18;319:3–9. doi: 10.1016/j.cellimm.2017.07.007

Fig. 3. Teplizumab down-modulates CD127 expression in circulating CD8 T cell subsets.

Fig. 3

Representative gating for CD127 expression on CD8 T cell subsets is shown in Supplemental Figure 2. (A) Frequency and (B) level of expression (MFI) of CD127 on CD8 T cell subsets over time. Data reported as mean ± SEM for Per Protocol participants in the teplizumab treatment arm. *<0.05, **<0.005, ***<0.0005 adjusted p value. C1, C2: Course 1 and 2. https://www.itntrialshare.org/AbATE_fig3.url